Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Ribavirin for treating Crimean Congo haemorrhagic fever

Esta versión no es la más reciente

ver la versión actual 05 junio 2018

Información

DOI:
https://doi.org/10.1002/14651858.CD012713Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 10 julio 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Enfermedades infecciosas

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Samuel Johnson

    Correspondencia a: Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK

    [email protected]

  • Nicola Maayan

    Cochrane Response, Cochrane, London, UK

  • Inga Mills

    Cochrane Response, Cochrane, London, UK

  • Brian S Buckley

    Department of Surgery, University of Phillipines, Manila, Philippines

  • Artemisia Kakourou

    Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece

  • Rachel Marshall

    London, UK

Contributions of authors

SJ and RM drafted the protocol, NM, IM, AK, and BSB aided in development of the protocol. All authors read and approved the final protocol draft.

Sources of support

Internal sources

  • Liverpool School of Tropical Medicine, UK.

External sources

  • Department for International Development, UK.

    Grant: 5242

  • World Health Organization (WHO), Switzerland.

    WHO Crimean‐Congo Hemorrhagic Fever Clinical Practice Guidelines Agreement for Performance of Work (APW) Grant 2017 (number 702828)

Declarations of interest

SJ has no known conflicts of interest.
RM has no known conflicts of interest.
NM has no known conflicts of interest.
IM has no known conflicts of interest.
AK has no known conflicts of interest.
BSB has no known conflicts of interest.

Acknowledgements

We would like to acknowledge the contribution made by Cochrane Response in the work carried out for this review and the comments and contribution made by WHO in the development of this protocol.

We would like to thank Karla Soares Weiser, Nick Henschke and Marty Richardson who contributed greatly to planning this protocol.

Also we are grateful to ROBINS‐I tool development team for methodological advice in using the ROBINS‐I tool.

Samuel Johnson and the editorial base of the Cochrane Infectious Diseases Group are supported by the Effective Health Care Research Consortium. This Consortium is funded by UK aid from the UK Government for the benefit of developing countries (Grant: 5242). The views expressed in this publication do not necessarily reflect UK government policy.

Version history

Published

Title

Stage

Authors

Version

2018 Jun 05

Ribavirin for treating Crimean Congo haemorrhagic fever

Review

Samuel Johnson, Nicholas Henschke, Nicola Maayan, Inga Mills, Brian S Buckley, Artemisia Kakourou, Rachel Marshall

https://doi.org/10.1002/14651858.CD012713.pub2

2017 Jul 10

Ribavirin for treating Crimean Congo haemorrhagic fever

Protocol

Samuel Johnson, Nicola Maayan, Inga Mills, Brian S Buckley, Artemisia Kakourou, Rachel Marshall

https://doi.org/10.1002/14651858.CD012713

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.